Moreover, we found that DICER1‐AS1 could effectively promote CRC progression by acting as a ceRNA that sponges miR‐650 to upregulate MAPK1, promoting ERK1/2 phosphorylation, and activating the MAPK/ERK signaling pathway. This evidence concerns the gene MAPK3 and colorectal carcinoma.